BioCentury
ARTICLE | Financial News

Synageva raises $155.7 million in follow-on

September 26, 2013 1:11 AM UTC

Synageva BioPharma Corp. (NASDAQ:GEVA) raised $155.7 million through the sale of 2.8 million shares at $56.63, its close Tuesday, in a follow-on underwritten by Goldman Sachs; Morgan Stanley; Cowen; and Canaccord. Synageva proposed the follow-on late Monday, when its share price was $54.22. On Wednesday, Synageva was up $5.05 to $61.68. ...